Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.10
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2012 | 2016 | 2017 | 2018 | 2019 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $150.1K | $0 | $1.8K | $805 | $0 | $0 | $0 |
| Cost of revenue | $972 | $0 | $2.0K | $11.0K | $0 | $0 | $0 | $0 |
| Gross profit | −$972 | $150.1K | −$2.0K | −$9.2K | $805 | $0 | $0 | $0 |
| Gross margin | — | 100.0% | — | -522.9% | 100.0% | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$755.9K | −$67.1K | −$233.3K | −$1.4M | −$1.4M | −$26.3K | −$12.5K | −$6.7K |
| EBITDA | −$754.9K | −$59.1K | −$231.4K | −$1.4M | −$1.4M | −$26.3K | −$12.5K | −$6.7K |
| Net income | −$755.9K | −$67.1K | −$233.3K | −$1.5M | −$1.4M | −$26.3K | −$12.5K | −$6.7K |
| Net margin | — | -44.7% | — | -82242.8% | -174816.8% | — | — | — |
| EPS (diluted) | -8.93 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | 0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
DRUG FREE SOLUTION INC
No one on the platform currently holds DSOL.
No tracked institution reports a position in DSOL as of their last filing.
No one on the platform has traded DSOL yet.
| $35M |
| — |
| LEEEFLeef Brands Inc. | $0.17 | +0.00% | $35M | — |
| MDDVFMedical Developments International Limited | $0.37 | +0.00% | $42M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.